Will Morton[email protected]Molecular ImagingPET/MRI shows promise in patients with large vessel vasculitisPET/MRI could be an invaluable tool for evaluating how patients with large vessel vasculitis respond to treatments, suggests a research team in Scotland.August 27, 2024AICommercial AI devices lack clinical validation, study findsCommercial AI devices that lack adequate clinical validation may pose risks for patient care – and that’s true of almost half the tools cleared so far by the U.S. FDA.August 26, 2024InterventionalAcute stroke intervention results in long-term benefitsThe benefits of endovascular thrombectomy in patients with acute basilar artery occlusion are sustained at long-term follow-up.August 26, 2024Molecular ImagingMicro-SPECT shows microplastics cause renal failure in miceMolecular imaging in mice has shown for the first time that environmental pollutants such as polyethylene microplastic could be a risk factor for kidney dysfunction.August 23, 2024Clinical NewsCan sustainability research span from ‘bedside to biosphere’?Two long-time leaders in U.S. radiology are encouraging the field to embrace a “bedside to biosphere” concept for advancing sustainability research.August 21, 2024Molecular ImagingPET scans predict patient response to PluvictoPET scans that determine whether men with prostate cancer are eligible for Pluvicto treatment can provide additional clues on how they may respond to the drug.August 20, 2024AICan AI help rule out ‘unremarkable’ chest x-rays?A commercial AI tool showed potential in off-label use for generating automatic reports for “unremarkable” chest x-rays.August 20, 2024Molecular ImagingFDG-PET scans can help predict risk of dementiaA normal brain F-18 FDG-PET scan can rule out the short-term risk of dementia in older patients who present with cognitive complaints.August 16, 2024Molecular ImagingSPECT/CT visualizes heart’s response to tafamidisSPECT/CT imaging can show over time how patients taking tafamidis for heart disease respond to the treatment.August 16, 2024Molecular ImagingNew theranostics delivery route tested for prostate cancerA new delivery route for theranostic agents via arteries rather than intravenous injections could dramatically increase their effects on tumors in patients with prostate cancer.August 13, 2024Previous PagePage 29 of 60Next PageTop StoriesMolecular ImagingEANM: Next-generation PET scanner cuts imaging time to one minuteThe scanner's fastest images were rated more highly on average than those from a standard PET/CT scanner.Augmented/Virtual RealityVR boosts accuracy, confidence for evaluating abdominal neuroblastomaMRIMRI shows features of scapular pain in patientsWomens ImagingCEM-guided biopsy effective for sampling suspicious breast findingsDigital X-RayRadiologists, LLMs fail at spotting AI-generated chest x-rays
